Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Myeloma | 11 | 2023 | 5181 | 1.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1061 | 0.470 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 380 | 0.440 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 693 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 1352 | 0.400 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2013 | 142 | 0.400 |
Why?
|
| Melphalan | 2 | 2022 | 431 | 0.340 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 199 | 0.340 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1596 | 0.290 |
Why?
|
| Paraproteinemias | 2 | 2022 | 246 | 0.280 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3523 | 0.270 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 13695 | 0.220 |
Why?
|
| Antibodies, Bispecific | 1 | 2023 | 164 | 0.200 |
Why?
|
| Karyopherins | 1 | 2021 | 137 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 1339 | 0.180 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 177 | 0.180 |
Why?
|
| Hydrazines | 1 | 2021 | 226 | 0.180 |
Why?
|
| Cardiac Tamponade | 1 | 2020 | 173 | 0.170 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 337 | 0.150 |
Why?
|
| Thalidomide | 2 | 2019 | 890 | 0.140 |
Why?
|
| Vasculitis | 1 | 2021 | 519 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 871 | 0.140 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2016 | 30 | 0.140 |
Why?
|
| Triazoles | 1 | 2021 | 911 | 0.130 |
Why?
|
| Pericardium | 1 | 2020 | 667 | 0.130 |
Why?
|
| Dexamethasone | 2 | 2019 | 1951 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5442 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2019 | 2618 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.110 |
Why?
|
| Vidarabine | 1 | 2013 | 345 | 0.100 |
Why?
|
| Plasma Cells | 2 | 2016 | 591 | 0.100 |
Why?
|
| Transplantation, Autologous | 3 | 2021 | 2124 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1758 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1580 | 0.090 |
Why?
|
| Polydeoxyribonucleotides | 2 | 2021 | 127 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 931 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4456 | 0.080 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2010 | 233 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3479 | 0.080 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2007 | 48 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2010 | 965 | 0.070 |
Why?
|
| Thymoma | 1 | 2007 | 186 | 0.070 |
Why?
|
| Humans | 20 | 2023 | 744343 | 0.070 |
Why?
|
| Neutropenia | 1 | 2010 | 895 | 0.060 |
Why?
|
| Pyrazines | 1 | 2010 | 1230 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
| Neoplasm, Residual | 2 | 2020 | 973 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2007 | 652 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2021 | 4445 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.050 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2021 | 19 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1877 | 0.050 |
Why?
|
| Viral Tropism | 1 | 2021 | 101 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2021 | 207 | 0.040 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2021 | 132 | 0.040 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2021 | 220 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 390 | 0.040 |
Why?
|
| Graft vs Host Disease | 2 | 2021 | 2957 | 0.040 |
Why?
|
| Thrombophilia | 1 | 2021 | 305 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2133 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 4665 | 0.040 |
Why?
|
| Reticulocyte Count | 1 | 2016 | 37 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2021 | 2008 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2022 | 40561 | 0.030 |
Why?
|
| Apoptosis | 2 | 2023 | 9727 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2016 | 290 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 20947 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 2203 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1531 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63114 | 0.030 |
Why?
|
| Heparin | 1 | 2021 | 1637 | 0.030 |
Why?
|
| DNA Damage | 1 | 2023 | 2432 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 2765 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1018 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2016 | 881 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 4776 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1270 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1620 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 16689 | 0.030 |
Why?
|
| Prognosis | 2 | 2022 | 29063 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 213383 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 40075 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
| Male | 7 | 2022 | 350118 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2020 | 2052 | 0.020 |
Why?
|
| Quality of Life | 2 | 2022 | 12804 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2094 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 163280 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6538 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 6895 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 270 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 214055 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
| Female | 5 | 2022 | 380194 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4245 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 1378 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4599 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2948 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15226 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 1751 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1338 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2016 | 3444 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.010 |
Why?
|
| Depression | 1 | 2022 | 7766 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 5179 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3507 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12959 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5974 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11483 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_